Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 03, 2024$2.60
P/E Ratio
N/A
Market Cap
$23.79M
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.
Overview
Trading Information
Company